Table 2 Average difference in the dose at the center of tumors between the calculated doses from the treatment planning system and the doses measured using TLD and EBT3 for the cone-based linac, the FFF-VMAT linac, and tomotherapy
From: Dosimetric comparison of different treatment modalities for stereotactic radiotherapy
Dosimeter | Cone-based linac | FFF-VMAT linac | Tomotherapy |
|---|---|---|---|
TLD (%) | −1.38 (−4.08 to 0.81) | −1.34 (−4.96 to 4.04) | 1.05 (−2.10 to 3.65) |
EBT3 (%) | −3.68 (−4.52 to −3.27) | −1.75 (−4.70 to 2.52) | −1.02 (−3.72 to 0.58) |